<DOC>
	<DOCNO>NCT00096824</DOCNO>
	<brief_summary>The purpose study determine often dementia neurological problem occur people HIV . Participants ACTG A5175 enroll study .</brief_summary>
	<brief_title>A Study Dementia Neurological Problems HIV Infected Patients Who Are Participating ACTG A5175</brief_title>
	<detailed_description>Both central peripheral nervous system ( CNS PNS ) affect HIV ; however , cause neurotoxicity HIV infect patient unknown . Initial data indicate many 40 % patient HIV develop form dementia . Other common neurological problem observe HIV patient peripheral neuropathy opportunistic infection CNS . Most antiretroviral drug use treatment HIV poor penetration CNS , may explain HIV persists CNS contribute prevalence dementia neurological disorder HIV infect patient . This study examine prevalence dementia neurological disorder participant ACTG A5175 , `` Once-Daily PI/NNRTI Therapy Combinations Treatment Naive , HIV Infected Patients Resource-limited Conditions . '' The study last approximately 2.5 3 year . Participants undergo neurological examination neuropsychological assessment entry step ACTG A5175 administration new antiretroviral regimen , every 24 week discontinue ACTG A5175 . Physicians make targeted diagnosis study visit .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Reverse Transcriptase Inhibitors</mesh_term>
	<criteria>HIV1 infect Prior antiretroviral therapy le 7 day time prior study entry CD4 count le 300 cells/mm3 Willing use acceptable mean contraception Plans stay area duration study participation Willing adhere study followup schedule ACTG A5175 study Have begin ACTG A5175 antiretroviral therapy , plan start therapy enrol study Any active severe psychiatric illness ( e.g. , schizophrenia , severe depression , severe bipolar affective disorder ) , opinion site investigator , may interfere study result Current drug alcohol abuse , opinion site investigator , would interfere study requirement Serious illness hospitalization , opinion site investigator , may interfere study result Any condition , opinion site investigator , would interfere study requirement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Acute Infection</keyword>
	<keyword>Treatment Naive</keyword>
</DOC>